Angon, Hamsia T.

HRN: 22-10-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2022
CEFUROXIME 1.5GM (VIAL)
12/03/2022
12/10/2022
IV
1.5g
Q8
UTI, CAP
Waiting Final Action 
12/09/2022
CEFUROXIME 500MG (TAB)
12/09/2022
12/10/2022
ORAL
500mg
BID
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: